Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.70 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.58 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.54 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.54 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | PAM | P19021 | 2/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | FAAH | O00519 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | POLA1 | P09884 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20564125 | 1.00 | DGKA (0.70) | DGKADNM1PRSS1PRSS2PRSS3 | |
| SCHEMBL5269856 | 1.00 | DGKA (0.70) | DGKADNM1PRSS1PRSS2PRSS3 | |
| SCHEMBL2139337 | 0.98 | DGKA (0.67) | DGKADNM1PRSS1PRSS2PRSS3 | |
| SCHEMBL25953980 | 0.96 | DGKA (0.66) | DGKADNM1PRSS1PRSS2PRSS3 | |
| SCHEMBL14449519 | 0.94 | DGKA (0.74) | DGKADNM1PRSS1PRSS2PRSS3 | |
| SCHEMBL17123126 | 0.94 | DGKA (0.74) | DGKADNM1PRSS1PRSS2PRSS3 | |
| SCHEMBL17123131 | 0.94 | DGKA (0.74) | DGKADNM1PRSS1PRSS2PRSS3 | |
| SCHEMBL11877869 | 0.94 | DGKA (0.74) | DGKADNM1PRSS1PRSS2PRSS3 | |
| SCHEMBL17123130 | 0.94 | DGKA (0.74) | DGKADNM1PRSS1PRSS2PRSS3 | |
| SCHEMBL17123133 | 0.94 | DGKA (0.74) | DGKADNM1PRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3625283-B1 | POLYESTER COPOLYMER | AVANTIUM KNOWLEDGE CENTRE BV (NL) | 2025-05-07 | — | — | EP | disclosed |
| US-11548980-B2 | Polyester copolymer | AVANTIUM KNOWLEDGE CENTRE B.V. (NL) | 2023-01-10 | — | — | US | disclosed |
| US-20210139645-A1 | Polyester Copolymer | AVANTIUM KNOWLEDGE CENTRE B.V. (NL) | 2021-05-13 | — | — | US | disclosed |
| EP-3625283-A1 | POLYESTER COPOLYMER | Avantium Knowledge Centre B.V. (NL) | 2020-03-25 | — | — | EP | disclosed |
| WO-2018211132-A1 | POLYESTER COPOLYMER | AVANTIUM KNOWLEDGE CENTRE B.V. (NL) | 2018-11-22 | — | — | WO | disclosed |
| EP-1478232-B1 | DIESTER DICARBOXYLATE ANTIMICROBIAL COMPOSITIONS AND METHODS EMPLOYING THEM | ECOLAB INC (US) | 2007-10-17 | — | — | EP | disclosed |
| US-6927237-B2 | Two solvent antimicrobial compositions and methods employing them | ECOLAB INC. (US) | 2005-08-09 | — | — | US | disclosed |
| US-20050096245-A1 | Two solvent antimicrobial compositions and methods employing them | ECOLAB INC. (US) | 2005-05-05 | — | — | US | disclosed |
| EP-1478232-A1 | DIESTER DICARBOXYLATE ANTIMICROBIAL COMPOSITIONS AND METHODS EMPLOYING THEM | ECOLAB INC. (US) | 2004-11-24 | — | — | EP | disclosed |
| WO-2003073849-A1 | DIESTER DICARBOXYLATE ANTIMICROBIAL COMPOSITIONS AND METHODS EMPLOYING THEM | ECOLAB INC. (US) | 2003-09-12 | — | — | WO | disclosed |
| US-20020168422-A1 | Two solvent antimicrobial compositions and methods employing them | ECOLAB USA INC. | 2002-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020168422-A1 | Two solvent antimicrobial compositions and methods employing them | TAS2R50, HDHD5, CEL | DGKA 1221/4885DNM1 1052/4885PRSS1 1018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.